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1607-551X/Copyright ª 2016, Kaohsiu
CC BY-NC-ND license (http://creativeAbstract To investigate Caspase-3 gene polymorphisms (rs4647693 G/A, rs4647610 A/G, and
rs12108497 T/C) and susceptibility to lumbar intervertebral disc herniation (LDH). The geno-
type frequency distributions of the polymorphisms were detected by polymerase chain reac-
tionerestriction fragment length polymorphism in 107 LDH patients (case group) and 121
healthy individuals (control group). SHEsis software was used to conduct gene linkage disequi-
librium and haplotype analysis. Regression analysis was used to analyze possible risk factors for
LDH. Statistically significant differences in family history of LDH, amateur sports, leisure activ-
ities, bed types, and spine load grade were found between the case and control groups. The
distribution of allele and genotype frequencies of rs4647693 G/A, rs4647610 A/G, and
rs12108497 T/C polymorphisms of Caspase-3 were significantly different between the case
and control groups. Haplotype analysis showed that the G-G-C (rs4647693-rs4647610-
rs12108497) haplotype might be a risk factor for LDH, whereas the A-A-T haplotype might be
a protective factor (p < 0.05). Binary logistic regression analysis showed that the GAþAA ge-
notype of rs4647693 was negatively associated with the risk of LDH, whereas high spine load
grade was positively associated with the risk of LDH. These findings revealed that
rs4647693 G/A, rs4647610 A/G, and rs12108497 T/C polymorphisms of Caspase-3 may be asso-
ciated with susceptibility to LDH and that interaction and modification effects may exist be-
tween Caspase-3 polymorphisms.
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Lumbar disc herniation (LDH), a type of chronic low back
pain syndrome, is caused by the degeneration and hernia-
tion of the nucleus pulposus of the intervertebral disc [1].
LDH remains a considerable clinical problem that can affect
up to 80% of individuals at any time in their lives, resulting in
important social and economic consequences [2]. Specif-
ically, LDH has an estimated worldwide incidence rate of
7.62% per year, with people aged 25e55 years at a higher risk
of developing LDH [3]. Generally, LDH is considered a com-
plex disease involving multifactorial interactions, but the
precise etiology and pathogenesis underlying LDH is complex
and still poorly understood. In the past few years, various
factors such as sex, age, height, smoking habits, and phys-
ical activity have been reported in the literature as being
associated with LDH [4e6]. In addition, recent molecular
epidemiological studies have highlighted the potential and
significant role of genetic variability in LDH [7e9]. To date,
with the completion of high-quality sequencing of the
human genome and a deeper understanding of disease
mechanisms at the cellular and molecular level, the genes
responsible for susceptibility to many complex diseases,
including LDH, have been identified [4,10].
Caspase-3, also known as CPP32/Yama/apopain, is one
of the most extensively studied apoptotic proteins in the
cysteineeaspartic acid protease (caspase) family and is
encoded by the Caspase-3 gene [11]. Caspase-3 acts as the
main executor of apoptosis and mediates both extrinsic and
intrinsic cell death signaling pathways [12]. Apoptosis is
considered an essential biological event, which is modu-
lated by the activation of multiple caspases, including
caspase-3, and plays a crucial role in cellular and tissue
homeostasis. Thus, the inappropriate regulation of
apoptosis might be one of the most important factors in
influencing the development and progression of many dis-
eases [13,14]. Therefore, it seemed biologically plausible
that genetic alterations of Caspase-3 might be involved in
the failure of apoptosis, which might lead to human dis-
eases such as LDH [15e17]. More importantly, there is ev-
idence suggesting that the failure of apoptosis could reduce
disc cell numbers and destroy normal disk function during
disc aging and degeneration, thus resulting in diminished
generation and organization, or ultimately leading to lum-
bar disc disease [18,19]. Thus, the Caspase-3 gene, as an
important apoptosis-related gene located at 4q35.1, is
naturally a good candidate gene for LDH.
To test this hypothesis, the present study was designed
to search for an association between Caspase-3 single-
nucleotide polymorphisms (SNPs) and haplotypes in LDH pa-




This study was approved by the ethics committee of
Changsha Central Hospital, Changsha, China, and all par-
ticipants signed informed consent forms before participating
in the research. The ethical approval for this studyconformed to the ethical principles for medical research
involving humans of the Helsinki Declaration.
Study participants
From January 2011 to January 2015, 107 LDH patients in the
spinal surgery department of Changsha Central Hospital and
First Affiliated Hospital of Guangxi Medical University were
enrolled in our experiment as the case group. All patients
were from the Chinese Han population and included 68 men
and 39 women, aged 19e58 years with a mean age of 38.75
 12.31 years. The diagnostic criteria were: (1) patients
who had a history of lumbar sprain and/or a history of
chronic strain; (2) patients who had pain in the inferior
lumbar part of the spine and regional sciatic nerve pain in
the leg caused by bed rest; (3) patients with tenderness
beside the lumbar spine that affects the leg or foot; (4)
patients whose lumbar flexion range was obviously limited;
(5) patients with positive results in the straight-leg raising
test and augmentation test (Bragard’s sign); (6) patients
who had the following nerve injury symptoms: muscular
atrophy, motor weakness, decreased sensation and hypo-
reflexia; and (7) patients with clinical manifestations of
LDH in accordance with imaging findings, including
computed radiography, computed tomography, and/or
magnetic resonance imaging. Exclusion criteria were: (1)
patients with mental illness or severe dysfunction of the
heart, lung, liver, or kidney; (2) patients with blood dis-
ease, diabetes, autoimmune disease, or tumors; and (3)
patients identified as underweight/malnourished with a
body mass index (BMI) < 18.5 kg/m2 or overweight/obese
with a BMI  28 kg/m2. A total of 121 healthy individuals
who received a physical examination in our hospital during
the same period were allocated to the control group,
including 71 men and 50 women, with an average age of
38.25  11.73 years. Inclusion criteria of the control group
were: (1) people of the Chinese Han ethnicity whose age
and sex were matched to the patients in the case group; (2)
good health as confirmed by physical examination; (3) no
recent infections; (4) no history of tumors; and (5) history
of lumbar sprain and/or chronic strain.
General information collected
(1) Spine load grade was based on the Swedish translated
version of the Short Musculoskeletal Function Assess-
ment Questionnaire (SMFA) [20], which is referred to as
the core and occupational classification system [21].
The classifications are as follows: Grade I: freelance
and less manual; Grade II: sedentary jobs; Grade III:
mainlywhole body vibration, bending over and twisting
work; andGrade IV: lifting and heavywork. (2) Smoking
was defined as having one or more cigarettes per day
for 1 year or longer, or as smoking > 18 packs of ciga-
rettes per year. (3) Drinking was defined as having two
ormoredrinks (of at least 100mL)everyweek for 1 year
or longer. (4) Amateur sports were defined as activities
performed after-working hours such as household
chores. (5) Leisure activities were defined as exercise
performed three times a week for at least 20 minutes
that led to an increased heart rate and sweating.
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The International Hapmap Project (Han Chinese in Beijing,
China; version 3.32; Whitehead Institute for Biomedical
Research, Cambridge, MA, USA; http://www.broad.mit.edu/
mpg/haploview/) [22] was used to determine frequencies of
SNPs in the Caspase-3 gene. Tag SNPs were selected using the
web-based Tagger algorithm (http://www.broad.mit.edu/
mpg/tagger/) with a minor allele frequency  0.05 and a
linkage disequilibrium coefficient of 0.8.
Sample collection
Peripheral venous blood was collected from all participants
in the early morning (07:00e08:00). Participants fasted for
10 hours prior to blood collection. After taking 2 mL of
blood, we added sodium citrate for anticoagulation and
preserved it at 4C. Genomic DNA was extracted from
whole blood samples using a Whole Blood Genomic DNA
Extraction Kit (Tiangen Biotech, Beijing, China) in accor-
dance with the manufacturer’s instructions. The purity and
concentration of the DNA samples were measured by 1%
agarose gel electrophoresis and spectrophotometer
(Shanghai Mapada Instrument, Shanghai, China) analysis.
Polymerase chain reactionerestriction fragment
length polymorphism detection
Polymerase chain reaction (PCR)erestriction fragment
length polymorphism was used for the detection of Cas-
pase-3 gene polymorphisms. Primer Premier 5.0 software
(Premier Biosoft International, Palo Alto, CA, USA) was used
for designing and verifying the PCR primers according to
each locus of Caspase-3. The primers were synthesized by
Shanghai Sangon Biotech (Shanghai, China) and the
sequenced are presented in Table 1. The Caspase-3 PCR
reaction system (20 mL) included: 1 mL of both forward and
reverse primers, 2.0 mL of template DNA, 7 mL of 2 Mix PCR
buffer, and 7 mL of distilled water. PCR conditions were:
5 minutes of initial denaturation at 94C, 30 seconds of
denaturation at 94C, 30 seconds of annealing at 58C, and
30 seconds of extension at 72C for 34 cycles, followed by a
5-minute extension at 72C. The PCR product was subjected
to RFLP testing. The whole reaction system (20 mL)Table 1 Primer sequences for Caspase-3.
Polymorphism Primer sequence (50e30)
rs4647693 F: AAT TCT GTT GCC ACC TTT
CG
R: ACC TTC TGC GTG TTT GCT
CT
rs4647610 F: AAC CGC TTC AAG AAA TCC
TG
R: ATC TGC CTT GTT GAG CCA
CT
rs12108497 F: AGC CGC TCA CGC ATC ATA
GT
R: AGT CCG CAT CCA GCC AGG
TAcontained 10 mL of PCR product, 12.5 mL of distilled water,
2 mL of enzyme digestion buffer and 0.5 mL of endonuclease
and underwent 4 hours of endonuclease digestion at 37C.
The digested products were run on a 1.5% agarose gel,
stained with ethidium bromide and observed and photo-
graphed under an ultraviolet gel imaging system.
Statistical analysis
Statistical analysis was performed using SPSS version 21.0
(SPSS Inc., Chicago, IL, USA). A Chi-square test was applied
to estimate whether the allele frequency distribution was
in accordance with HardyeWeinberg equilibrium. Mea-
surement data were expressed as the mean  standard
deviation. The difference between the two groups was
compared using t test. Enumeration data were detected by
c2-test. Odds ratios (ORs) and 95% confidence intervals (CIs)
were calculated to determine the relative risk of LDH. The
haplotype analysis was performed using SHEsis software
(http://analysis.bio-x.cn/SHEsisMain.htm). Binary logistic
regression analysis was used to identify whether the clinical
factors were the risk factors for LDH. All tests were two-
sided, and a significant difference was indicated when
p < 0.05.
Results
Comparison of clinical data
As shown in Table 2, there were 107 patients in the case
group, including 68 men and 39 women with a mean age of
38.75  12.31 years. There were 121 individuals in the
control group (71 men and 50 women with a mean age of
38.25  11.73 years). There were no significant differences
in age, sex, BMI, smoking history, or drinking history be-
tween the case and control groups (all p > 0.05). However,
comparisons of the family history of LDH, amateur sports,
leisure activities, bed types, and spine load grade between
the case and control group revealed significant differences
(all p < 0.05).
Genotype and allele frequency distribution of
rs4647693, rs4647610, and rs12108497 SNPs in the
case and control groups
The results of the HardyeWeinberg Equilibrium showed that
the genotype frequency distributions of Caspase-3 SNPs
rs4647693, rs4647610, and rs12108497 in the case and con-
trol groups were in line with genetic balance (all p > 0.05),
which showed that the genotype frequency of the three
SNPs were at equilibrium and were representative. Pairwise
linkage disequilibrium in Caspase-3 was examined using
Haploview software (Broad Institute of MIT and Harvard,
Cambridge, MA, USA). Linkage disequilibrium existed be-
tween rs4647610 and rs12108497 (r2 Z 0.882, D Z 0.946;
Table 3). As shown in Table 4, the genotype and allele fre-
quencies of Caspase-3 SNPs rs4647693, rs4647610, and
rs12108497 in the case and control groups were significantly
different (all p < 0.05). In the case group, the mutant ge-
notype (GA), recessive models (GAþAA), and A allele might
Table 2 Comparison of clinical data in case and control groups.
Case group (n Z 107) Control group (n Z 121) c2/t p
Age (y) 38.75  12.31 38.25  11.73 0.314 0.754
Sex (male/female) 68/39 71/50 0.567 0.452
BMI (kg/m2) 23.07  2.95 22.96  3.10 0.274 0.785
Family history of LDH (yes/no) 21/86 11/110 5.224 0.022
Smoking history (yes/no) 40/67 39/82 0.666 0.415
Drinking history (yes/no) 16/91 20/101 0.106 0.745
Amateur sports (yes/no) 24/83 45/76 5.862 0.016
Leisure activities (yes/no) 75/32 108/13 10.640 0.001
Bed types
Soft bed 31 17
Hard bed 76 104 7.608 0.006
Spine load grade
1e2 48 95
3e4 59 26 27.500 < 0.001
Data are presented as mean  standard deviation or n.
BMI Z body mass index; LDH Z lumbar disc herniation.
Significant differences (p < 0.05) are noted in bold.
Table 3 The linkage disequilibrium parameters of
TagSNPs in Caspase-3.
rs4647610 rs12108497
D0 r2 D0 r2
rs4647693 0.790 0.563 0.608 0.465
rs4647610 d d 0.946 0.882
Caspase-3 gene polymorphism and LDH 555be the protective factor for LDH (GA vs. GG: OR Z 0.048,
95% CI Z 0.011e0.206; GAþAA vs. GG: OR Z 0.250, 95%
CIZ 0.250; and A vs. G: ORZ 0.522, 95% CIZ 0.294e0.922).
Both mutant genotype (GG/AG) and G allele frequencies of
rs4647610 were higher in the case group (all p < 0.05)
compared to the control group, suggesting that the G allele
may be the risk factor for LDH (AG vs. AA: ORZ 3.254, 95%
CI Z 1.245e8.506; GG vs. AA: OR Z 1.803, 95%
CI Z 1.007e3.229; AGþGG vs. AA: OR Z 2.064, 95%
CI Z 1.205e3.533; and G vs. A: OR Z 1.782, 95%
CIZ 1.210e2.625). The TT genotype of rs12108497, as well
as the CC genotype and the C allelemight increase the risk of
LDH by 2.022-fold (95% CI Z 1.110e3.682, p < 0.05) and
1.833-fold (95%CIZ 1.234e2.722, p < 0.05).
Analysis of different Caspase-3 SNPs and clinical
data
No significant differences were found between the geno-
types of Caspase-3 SNPs rs4647693, rs4647610, and
rs12108497 and age, sex, BMI, smoking history, drinking
history, amateur sports, leisure activities, and bed types
(all p > 0.05). Significant differences in family history of
LDH and spine load grade were found between the poly-
morphic wild-type genotype and the mutant genotypes of
rs4647610 and rs12108497 (all p < 0.05). Additionally, for
the polymorphic wild-type genotype (GG) and mutant ge-
notype (GAþAA) of rs4647693 in the case and control
group, smoking was also significantly different (p < 0.05;
Table 5).Haplotype analysis
The haplotypes of three loci in the Caspase-3 gene are
shown in Table 6. We applied SHEsis software (http://
analysis.bio-x.cn/SHEsisMain.htm) to analyze the haplo-
types of the three loci of the participants from the case and
control groups. Haplotype frequencies lower than 3% were
excluded. The results showed that among the five haplo-
types, the A-A-T (rs4647693-rs4647610-rs12108497) haplo-
type appeared to be a protective factor against LDH
(OR Z 0.521, 95% CI Z 0.294e0.922, p Z 0.024), whereas
G-G-C appeared to be a risk factor for LDH (OR Z 2.075,
95% CI Z 1.364e3.156, p < 0.001).
Logistic regression analysis
Binary logistic regression analysis was performed to obtain
an updated OR-Exp (B) with LDH as the dependent variable
and family history of LDH, amateur sports, leisure activ-
ities, bed types, spine load grade, genotypes of Caspase-3
(rs4647693 (GAþAA/GG), rs4647610 (AA/AGþGG), and
rs12108497 (TCþCC/TT) as independent variables. The
analysis showed that the GAþAA genotype of rs4647693 was
a protective factor for the risk of LDH (p < 0.05), whereas
spine load grade was an independent risk factor for LDH
(p < 0.05; Table 7).
Discussion
LDH, one of the most typical musculoskeletal diseases, has
various genetic and environmental factors, but the patho-
genic mechanism of LDH is still unclear. In the present study,
we conducted a controlled case study of three SNP sites in
the Caspase-3 gene, rs4647693, rs4647610, and rs12108497,
to determine the relationship between the gene and LDH
risk. Our study has shown that the genotype and allele fre-
quencies of rs4647693, rs4647610, and rs12108497 in the
Caspase-3 gene were significantly different between the
LDH patients and the controls, suggesting that Caspase-3
Table 4 The genotype frequency distributions of Caspase-3 SNPs rs4647693, rs4647610, and rs12108497 in patient and control
groups.
Case group (n Z 107) Control group (n Z 121) c2 OR (95% CI) p
rs4647693 GG 96 83
GA 2 36 12.230 0.048 (0.011e0.206) < 0.001
AA 9 2 3.330 0.257 (0.054e1.224) 0.068
GAþAA 11 38 15.020 0.250 (0.120e0.521) < 0.001
G 194 (90.65) 202 (82.64) Ref
A 20 (9.35) 40 (17.36) 5.128 0.522 (0.294e0.922) 0.024
rs4647610 AA 54 82
AG 15 7 6.242 3.254 (1.245e8.506) 0.013
GG 38 32 3.975 1.803 (1.007e3.229) 0.046
AGþGG 53 39 7.062 2.064 (1.205e3.533) 0.008
A 123 (57.48) 171 (70.66) Ref
G 91 (42.52) 71 (29.34) 8.619 1.782 (1.210e2.625) 0.003
rs12108497 TT 60 83
TC 9 12 0.006 1.038 (0.411e2.619) 0.938
CC 38 26 5.380 2.022 (1.110e3.682) 0.020
TCþCC 47 38 3.807 1.711 (0.996e2.941) 0.051
T 129 (60.28) 178 (73.55) Ref
C 85 (39.72) 64 (26.45) 9.096 1.833 (1.234e2.722) 0.003
CI Z confidence interval; OR Z odds ratio.
Significant differences (p < 0.05) are noted in bold.
Table 5 Analysis of different genotypes and clinical data.
n rs4647693 p rs4647610 p rs12108497 p
GAþAA GG AGþGG AA TCþCC TT















Male 68 9 59 33 35 30 38














Family history of LDH
Yes 21 2 19 15 6 14 7
No 86 9 77 0.899 38 48 0.025 33 53 0.019
Smoking history
Yes 40 5 35 21 19 18 22
No 67 6 61 0.559 32 35 0.635 29 38 0.863
Drinking history
Yes 16 0 16 10 6 10 6
No 91 11 80 0.142 43 48 0.261 37 54 0.105
Amateur sports
Yes 24 5 19 13 11 12 12
No 83 6 77 0.053 40 43 0.606 35 48 0.496
Leisure activities
Yes 75 10 65 35 40 31 44
No 32 1 31 0.111 18 14 0.364 16 16 0.408
Bed types
Soft bed 31 3 28 18 13 18 13
Hard bed 76 8 68 0.896 35 41 0.260 29 47 0.060
Spine load grade
1e2 48 10 38 15 33 14 34
3e4 59 1 58 0.001 38 21 <0.001 33 26 0.006
Data are presented as mean  standard deviation or n.
BMI Z body mass index; LDH Z lumbar disc herniation.
Significant differences (p < 0.05) are noted in bold.
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Table 6 Haplotype frequencies of rs4647693, rs4647610 and rs12108497 in Caspase-3 gene in both the case and the control.
Haplotype
(rs4647693-rs4647610-rs12108497)
Case (freq) Control (freq) c2 Fisher p OR (95%CI)
AAT 20 (0.093) 40 (0.165) 2.152 0.024 0.521 (0.294e0.922)
GAC 10 (0.047) 14 (0.058) 0.290 0.590 0.796 (0.347e1.828)
GAT 93 (0.434) 117 (0.483) 1.085 0.298 0.822 (0.568e1.189)
GGC 75 (0.350) 50 (0.206) 11.851 < 0.001 2.075 (1.364e3.156)
GGT 16 (0.075) 21 (0.087) 0.226 0.063 0.849 (0.431e1.670)
CI Z confidence interval; OR Z odds ratio.
Significant differences (p < 0.05) are noted in bold.
Table 7 Binary logistic regression analysis for investigating the association between lumbar disc herniation risk and Caspase-3
gene polymorphisms.
Independent variable B SE Wald df p Exp (B) 95% CI for Exp (B)
Lower Upper
Family history of lumbar disc herniation 0.800 0.528 2.297 1 0.130 0.449 0.160 1.264
Amateur sports 0.577 0.369 2.445 1 0.118 1.781 0.864 3.671
Leisure activities 0.790 0.458 2.980 1 0.084 2.203 0.899 5.402
Bed types 0.895 0.466 3.691 1 0.055 0.409 0.164 1.018
Spine load grade 1.756 0.410 18.348 1 < 0.001 0.173 0.077 0.386
rs4647693 3.064 0.604 25.764 1 < 0.001 0.047 0.014 0.153
rs4647610 0.072 0.459 0.024 1 0.876 0.931 0.379 2.288
rs12108497 0.118 0.463 0.064 1 0.800 1.125 0.454 2.789
B Z partial regression coefficient; df Z degree of freedom; Exp (B) Z odds ratio; SE Z standard error; Wald Z Wald c2.
Significant differences (p < 0.05) are noted in bold.
Caspase-3 gene polymorphism and LDH 557gene polymorphisms might be used as genetic determinants
for LDH susceptibility. In particular, our findings provide a
quantitative basis for the three SNPs in the Caspase-3 gene
as a risk factor for or a protective factor against the sus-
ceptibility of LDH. For instance, the Caspase-3 rs4647693
SNP, which was identified as a protective factor, was related
to a decreased risk of LDH; whereas rs4647610 and
rs12108497 SNPs were both associated with a significantly
elevated risk of disc degeneration, suggesting that these
Caspase-3 variants are likely to be susceptibility markers for
LDH. These results could be due to the fact that the genetic
polymorphisms of rs4647610 and rs12108497 may affect LDH
susceptibility by changing the transcription efficiency and
function of the Caspase-3 gene, which is considered as a
major player in the apoptotic process [15]. To some extent,
apoptosis may have an important role in maintaining normal
disk function by eliminating aberrant cells [18]. As discussed
above, the impaired activity of Caspase-3 might be con-
nected to LDH risk [23].
In addition, we found statistically significant differences
in family history of LDH, amateur sports, leisure activities,
bed types, and lumbar load grade between the two study
groups. By contrast, no significant differences were
observed regarding age, sex, BMI, smoking, or drinking,
which made it possible for us to analyze further the inter-
action between the environmental factors and Caspase-3.
Because many complex diseases are caused by the
interaction between genetic and environmental factors, we
also examined a possible genetic association between the
genotypes and environmental risk factors, including smok-
ing, bed type, amateur sports, and leisure activities.According to our study, all three SNPs in Caspase-3 had an
association with spine load grade and high lumbar load
grade, which contribute significantly to the risk of LDH.
Comparable results were reported in previous studies,
which highlighted the pivotal role of lumbar load in leading
to excessive apoptosis of disk cells and structural changes
in intervertebral discs, thus playing an etiologic role in the
development of lumbar disc narrowing, as well as LDH
[24e26]. In addition, family history of LDH showed a
significantly increased correlation with Caspase-3
rs4647693 genotypes among patients, which might strongly
confer individual LDH susceptibility. Furthermore, previous
family and twin studies have documented the substantial
heritability of LDH and support the notion that familial
susceptibility is a pathogenic factor to lumbar degenera-
tion, which could elevate LDH risk [27,28].
Our findings of the relation between the three SNPs in
Caspase-3 and the risk of LDH further strengthen the find-
ings from the single-locus analyses, which revealed that
haplotype G-G-C (rs4647693-rs4647610-rs12108497) of
these three variants was also associated with increased risk
of LDH, whereas A-A-T haplotype was associated with a
reduced occurrence of LDH. These findings suggest that the
development of LDH could be influenced by SNP, as well as
haplotype differences. Additionally, logistic regression
analysis showed that both spine load grade and the Cas-
pase-3 rs4647693 polymorphism were closely related with
LDH and were independent risk factors for LDH.
As for the present study, some limitations that may bias
our analyses should be taken into consideration. First of all,
the studied group of patients is too small to make arbitrary
558 Y. Fang et al.conclusions regarding genetic polymorphisms in the Cas-
pase-3 gene. Therefore, a larger and well-designed analysis
based of different populations is required to elucidate fully
the relevant mechanisms in future research. Second, all of
the study participants were matched for sex and
geographical area, which would have reduced the effect of
population stratification, although it cannot be fully
excluded. Furthermore, we will continue to explore other
gene polymorphisms and combinations of polymorphisms to
search for the potential causes of LDH.
Conclusion
Our study provides strong evidence that Caspase-3
rs4647693, rs4647610, and rs12108497 SNPs are tightly
linked to genetic susceptibility to LDH, and their haplotypes
are greatly associated with the risk of LDH. Furthermore,
the association between Caspase-3 genetic polymorphisms
and LDH risk also appears to be influenced by spine load
grade and family history. Therefore, these findings may
lead to a better understanding of the pathogenic mecha-
nisms of LDH and suggest promising targets for treatment
and novel therapeutic strategies for LDH.
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